Thromboprophylaxis after Knee Arthroscopy and Lower-Leg Casting

Two trials, one involving patients undergoing knee arthroscopy and one involving patients with lower-leg casting, evaluated low-molecular-weight heparin as clot prophylaxis. The incidence of symptomatic venous thromboembolism was low, and anticoagulation did not influence it. Patients who undergo ar...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 376; no. 6; pp. 515 - 525
Main Authors van Adrichem, Raymond A, Nemeth, Banne, Algra, Ale, le Cessie, Saskia, Rosendaal, Frits R, Schipper, Inger B, Nelissen, Rob G.H.H, Cannegieter, Suzanne C
Format Journal Article
LanguageEnglish
Published United States Massachusetts Medical Society 09.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Two trials, one involving patients undergoing knee arthroscopy and one involving patients with lower-leg casting, evaluated low-molecular-weight heparin as clot prophylaxis. The incidence of symptomatic venous thromboembolism was low, and anticoagulation did not influence it. Patients who undergo arthroscopic knee surgery and patients who are treated with casting of the lower leg are at increased risk for venous thromboembolism (i.e., deep-vein thrombosis or pulmonary embolism). 1 , 2 Venous thromboembolism is an important health problem that is associated with considerable mortality, morbidity, and resource expenditure. 3 – 5 The use of pharmacologic thromboprophylaxis after most orthopedic interventions is well established, because it strongly reduces the risk of thrombosis while only slightly increasing the risk of bleeding. 6 – 8 However, whether such prophylaxis is effective after arthroscopic knee surgery is uncertain, despite the fact that this procedure is the most commonly . . .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-News-2
ObjectType-Feature-3
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa1613303